TrialThe New England journal of medicine2021

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

Ann R Falsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.